Sinocare iCan CGM is a continuous blood glucose monitor that provides 15 days of monitoring without finger prick, with results available every 3 minutes.

Sinocare iCan CGM is a continuous blood glucose monitor that provides 15 days of monitoring without finger prick, with results available every 3 minutes.

฿1699.0

Pack

Product Details

The SinoCare iCan i3 All-in-1 CGM continuous blood glucose meter has a built-in battery that lasts 15 days, equivalent to 7,140 blood pricks. It provides blood glucose readings every 3 minutes, eliminating the need for constant phone contact. Data can be updated via mobile phone when connected.


Product details

⭐️ Connect for continuous, real-time glucose monitoring every 3 minutes.

⭐️ iCan is waterproof up to 8 feet for 2 hours.

⭐️ Connect your phone via Bluetooth using the app.

⭐️ Valid for 15 days

⭐️ Taking glucose readings every 3 minutes.

⭐️ Provides 7200 sensor readings.

⭐️ No finger piercing required.

⭐️ No need for a test result comparison certificate.

⭐️ Compact size (32 mm x 5.7 mm)

⭐️ Weight (approximately 6 grams)

⭐️ Water resistant (IP28: Waterproof up to 2.5 meters for 2 hours)

⭐️ Alert system for high or low blood sugar levels.

ICan I3 | CGM (Continuous Blood Glucose Monitoring) for 15 days, All-In-1, replaces 7,160 blood glucose tests.

CGM (Continuous Glucose Monitoring)

⭐️ FDA Registration Number: 66-2-2-2-0016106

⭐️ Thai Language Guide

⭐️ Valid for 15 days or replaces 7,160 blood draws.

⭐️ Weighs only 6 grams, diameter 32mm (slightly larger than a ten-baht coin)

⭐️ Has a built-in battery and connects to the app via Bluetooth.

⭐️ Via the iCan app, available on both the App Store and Play Store.

⭐️ Legitimately imported product, with Thai warranty.

⭐️ The recommended placement is on the abdomen, away from the navel.

⭐️ Beware of counterfeit and illegally imported products.

⭐️ The version sold in China does not support the app in Thailand and there is no warranty or claim process.

⭐️ CGM (Continuous Mass Gadget) was included in the US healthcare system as of 2023. At least 15 million CGMs have been used, and this number is expected to increase every year.


For the group of people below.

⭐️ For health-conscious individuals.

⭐️ Type 1 diabetes patients

⭐️ Type 2 diabetes patients